# Nephris Srl

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nephris

- Industry: Biotechnology
- Headquarters: Milan, Italy
- Website: www.nephris.com/
- Total disclosed funding: $3.2M
- Latest round: Seed (Apr 20, 2022)
- Investors on record: 1

## About

Founded in 2021 by Paolo Fiorina and Francesca D’Addio, and based in Italy, Nephris Srl operates as a pre-clinical-stage biotech company focused on new targets of kidney disease progression. In April 2022, Nephris Srl raised EUR 3 million in seed funding from investor Sofinnova Partners.

The company offers research and development of therapies in diabetic nephropathy that, can improve kidney function. The company deals with patients suffering from type 1 and type 2 diabetes and offers new treatments that could prevent, treat, and reverse diabetic kidney disease. The platform also provides research and treatment for chronic kidney diseases.

## Funding rounds

- Seed, Apr 20, 2022, $3.2M — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed